Kandi Technologies Group, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024022676 Filed on March 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$67.70M	$67.70M
YoY Change	-59.03%	-59.03%
Cash & Equivalents	$33.76M	$33.76M
Short-Term Investments	$33.95M	$33.95M
Other Short-Term Assets	$64.39M	$64.39M
YoY Change	19420.74%	-11.91%
Inventory	$61.55M	$61.55M
Prepaid Expenses	$1.909M
Receivables	$18.95M	$18.95M
Other Receivables	$6.477M	$130.9M
Total Short-Term Assets	$343.5M	$343.5M
YoY Change	4.32%	4.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$98.80M	$104.7M
YoY Change	1.68%	0.91%
Goodwill	$33.15M
YoY Change	-0.1%
Intangibles	$6.396M
YoY Change	-19.99%
Long-Term Investments	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Assets	$9.993M	$4.918M
YoY Change	-6.0%	-13.41%
Total Long-Term Assets	$151.9M	$151.9M
YoY Change	-1.14%	-1.14%
TOTAL ASSETS
Total Short-Term Assets	$343.5M	$343.5M
Total Long-Term Assets	$151.9M	$151.9M
Total Assets	$495.5M	$495.5M
YoY Change	2.58%	2.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.74M	$28.74M
YoY Change	-18.62%	-18.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$9.072M	$33.14M
YoY Change	62.01%	34.23%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$76.67M	$76.67M
YoY Change	-5.93%	-5.93%
LONG-TERM LIABILITIES
Long-Term Debt	$8.400M	$8.389M
YoY Change
Other Long-Term Liabilities	$227.0K	$2.920M
YoY Change	-62.29%	21.41%
Total Long-Term Liabilities	$12.27M	$11.31M
YoY Change	224.38%	370.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$76.67M	$76.67M
Total Long-Term Liabilities	$12.27M	$11.31M
Total Liabilities	$88.95M	$91.33M
YoY Change	4.29%	6.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.33M
YoY Change	-0.04%
Common Stock	$457.9M
YoY Change	1.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$404.1M	$404.1M
YoY Change
Total Liabilities & Shareholders Equity	$495.5M	$495.5M
YoY Change	2.58%	2.58%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-33997
CY2023	dei	Entity Registrant Name EntityRegistrantName	KANDI TECHNOLOGIES GROUP, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0363723
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Jinhua New Energy Vehicle Town
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Jinhua
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Zhejiang Province
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	321016
CY2023	dei	City Area Code CityAreaCode	(86 - 579)
CY2023	dei	Local Phone Number LocalPhoneNumber	82239856
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	KNDI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	237630412.8	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	87358234	shares
CY2023	dei	Auditor Name AuditorName	ARK Pro CPA & Co
CY2023	dei	Auditor Location AuditorLocation	Hong Kong, China
CY2023	dei	Auditor Firm AuditorFirmId	3299
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33756941	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84063717	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	59873127	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	66976554	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	33947212	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	81191191	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2886223	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2285386	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18951745	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38150876	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	61551268	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	40475366	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	124473111	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	434461	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6476542	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	11912615	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1909094	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2970261	usd
CY2023Q4	kndi	Advances To Suppliers AdvancesToSuppliers	2609098	usd
CY2022Q4	kndi	Advances To Suppliers AdvancesToSuppliers	3147932	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	343548138	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	329322973	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	98803772	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	97168753	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6395825	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7994112	usd
CY2023Q4	kndi	Land Use Rights Net LandUseRightsNet	2754442	usd
CY2022Q4	kndi	Land Use Rights Net LandUseRightsNet	2909950	usd
CY2022Q4	kndi	Constructions In Progress Gross ConstructionsInProgressGross	199837	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	814610	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1432527	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	144984	usd
CY2023Q4	us-gaap	Goodwill Goodwill	33146682	usd
CY2022Q4	us-gaap	Goodwill Goodwill	33178229	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9993130	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10630911	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	151908461	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	153659303	usd
CY2023Q4	us-gaap	Assets Assets	495456599	usd
CY2022Q4	us-gaap	Assets Assets	482982276	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28744854	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	35321262	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	7252814	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	14131414	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	9072336	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5569154	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	24071461	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	19123476	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2130083	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1270617	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5402081	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6089925	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	76673629	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	81505848	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8389163	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	963691	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1378372	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2693000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1803000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	227024	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	602085	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12272878	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3783457	usd
CY2023Q4	us-gaap	Liabilities Liabilities	88946507	usd
CY2022Q4	us-gaap	Liabilities Liabilities	85289305	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87532800	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77668730	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87348234	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74180171	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	87533	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	77669	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	184566	shares
CY2023Q4	kndi	Treasury Stock Average Price TreasuryStockAveragePrice	2.75
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3488559	shares
CY2022Q4	kndi	Treasury Stock Average Price TreasuryStockAveragePrice	2.81
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	507013	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	9807820	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-36970066	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-28333239	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	457847155	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	451373645	usd
CY2023Q4	kndi	Restricted Portion Of Accumulated Deficit RestrictedPortionOfAccumulatedDeficit	4422033	usd
CY2022Q4	kndi	Restricted Portion Of Accumulated Deficit RestrictedPortionOfAccumulatedDeficit	4422033	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16332633	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16339765	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	404124976	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	396970490	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	2385116	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	722481	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	406510092	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	397692971	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	495456599	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	482982276	usd
CY2023	us-gaap	Revenues Revenues	123599232	usd
CY2022	us-gaap	Revenues Revenues	117813049	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	82229209	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	98295323	usd
CY2023	us-gaap	Gross Profit GrossProfit	41370023	usd
CY2022	us-gaap	Gross Profit GrossProfit	19517726	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4265176	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6029608	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13335950	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5501475	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	35381496	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32325889	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	496981	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	642665	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	942591	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	2697521	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	54422194	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	47197158	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-13052171	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-27679432	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	9984558	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	6427502	usd
CY2023	us-gaap	Interest Expense InterestExpense	1327341	usd
CY2022	us-gaap	Interest Expense InterestExpense	707488	usd
CY2023	kndi	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-1803000	usd
CY2022	kndi	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-4196995	usd
CY2023	kndi	Government Grants Income Nonoperating GovernmentGrantsIncomeNonoperating	2017551	usd
CY2022	kndi	Government Grants Income Nonoperating GovernmentGrantsIncomeNonoperating	1639328	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4047074	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2784561	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16524842	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14340898	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3472671	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13338534	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1802904	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-487510	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1669767	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-12851024	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1662635	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-727361	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7132	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12123663	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8636827	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-28585025	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6967060	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41436049	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78781094	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75571702	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79902891	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75571702	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	443200327	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	746920	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1231566	usd
CY2022	kndi	Stock Buyback StockBuyback	7499635	usd
CY2022	kndi	Noncontrolling Interest Increase Capital Contribution From Shareholder NoncontrollingInterestIncreaseCapitalContributionFromShareholder	1449842	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-12851024	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-28585025	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	397692971	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9368878	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3476058	usd
CY2023	kndi	Stock Buyback StockBuyback	510744	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3449989	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1669767	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8636827	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	406510092	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1669767	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-12851024	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11913647	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12427973	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1439573	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	3340186	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	656330	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-542801	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	203236	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-461045	usd
CY2023	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	141389	usd
CY2023	kndi	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-1803000	usd
CY2022	kndi	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-4196995	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	11059801	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1926376	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10560521	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20965140	usd
CY2023	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	123992862	usd
CY2022	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-4726570	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21531323	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9145298	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-5165337	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	4932463	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1491762	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-16275678	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	38603301	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	62592477	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-5062494	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	7842715	usd
CY2023	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-32629627	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-24533127	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	954006	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-25171	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-101160636	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31478911	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13172512	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3690235	usd
CY2023	kndi	Loan To Repayment From Third Party LoanToRepaymentFromThirdParty	-75185	usd
CY2022	kndi	Loan To Repayment From Third Party LoanToRepaymentFromThirdParty	-129894	usd
CY2023	kndi	Payments To Acquire Restricted Certificates Of Deposits PaymentsToAcquireRestrictedCertificatesOfDeposits	-45244390	usd
CY2022	kndi	Payments To Acquire Restricted Certificates Of Deposits PaymentsToAcquireRestrictedCertificatesOfDeposits	31210986	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-282135	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	32278828	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35031115	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	23420534	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	30765776	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	19709663	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	28357211	usd
CY2023	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-46426	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	8225000	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	757981	usd
CY2023	kndi	Proceeds From Purchase Of Treasury Stock ProceedsFromPurchaseOfTreasuryStock	-510745	usd
CY2022	kndi	Proceeds From Purchase Of Treasury Stock ProceedsFromPurchaseOfTreasuryStock	-7499634	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3449988	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14828688	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4333088	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-54053120	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7885292	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3357083	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9750444	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	151040271	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	168676007	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93630068	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	151040271	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33756941	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84063717	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	59873127	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	66976554	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	311504	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	350002	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	965025	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	345451	usd
CY2022	kndi	Common Stock Issued From Settlement Of Payables Related To Acquisitions CommonStockIssuedFromSettlementOfPayablesRelatedToAcquisitions	393986	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	1812005	usd
CY2010Q2	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	0.50	pure
CY2020Q3	kndi	Ownership Acquisition Percentage OwnershipAcquisitionPercentage	0.90	pure
CY2023Q4	kndi	Working Capital WorkingCapital	266874509	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33756941	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84063717	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	59873127	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	66976554	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	33947212	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	81191191	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8400000	usd
CY2023	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: transparent">NOTE 3 - BASIS OF PRESENTATION</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: transparent"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: transparent">The Company’s financial statements and notes are the representations of the Company’s management. Accounting policies adopted by the Company conform to generally accepted accounting principles in the United States and have been consistently applied in the Company’s presentation of its financial statements.</p>
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	24071461	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	19123476	usd
CY2023Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	2693000	usd
CY2022Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	1803000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	59873127	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	66976554	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	2886223	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	2285386	usd
CY2022	kndi	Outstanding Balance Account Receivable OutstandingBalanceAccountReceivable	40436262	usd
CY2022	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	36251108	usd
CY2023	kndi	Outstanding Balance Account Receivable OutstandingBalanceAccountReceivable	21837968	usd
CY2023	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	9997750	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	124473111	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	434461	usd
CY2023	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	942591	usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	2697521	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	4265176	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	6029608	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	2017551	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	1639328	usd
CY2023Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	7.0698	pure
CY2022Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.8973	pure
CY2023Q4	kndi	Foreign Currency Average Exchange Rate ForeignCurrencyAverageExchangeRate	7.0727	pure
CY2022Q4	kndi	Foreign Currency Average Exchange Rate ForeignCurrencyAverageExchangeRate	6.7284	pure
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	496981	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	642665	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1489657	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1965490	usd
CY2023	kndi	Impairment Of Intangible Asset Finitelived ImpairmentOfIntangibleAssetFinitelived	942591	usd
CY2022	kndi	Impairment Of Intangible Asset Finitelived ImpairmentOfIntangibleAssetFinitelived	2697521	usd
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2022Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.50	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1121797	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.07
CY2023	kndi	Expiration Period ExpirationPeriod	May 2023
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	21837968	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	40436262	usd
CY2023Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	2886223	usd
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	2285386	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18951745	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38150876	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3053277	usd
CY2022	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	456974	usd
CY2022	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	999775	usd
CY2022	kndi	Accounts Receivable Exchange Rate Difference AccountsReceivableExchangeRateDifference	225090	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2285386	usd
CY2023	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	690236	usd
CY2023	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	33906	usd
CY2023	kndi	Accounts Receivable Exchange Rate Difference AccountsReceivableExchangeRateDifference	55493	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2886223	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6248888	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6551450	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	88794	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4061146	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4114550	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	51241234	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	29809366	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	61551268	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	40475366	usd
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	434461	usd
CY2023	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	124473111	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	124473111	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	434461	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	124473111	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	151666180	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	141408138	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	52862408	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	44239385	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	98803772	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	97168753	usd
CY2023	kndi	Production Capacity Annual Output ProductionCapacityAnnualOutput	100000	shares
CY2023	us-gaap	Depreciation Depreciation	10141120	usd
CY2022	us-gaap	Depreciation Depreciation	10165138	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	8178574	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	24200000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15608085	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14942680	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-5702024	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-4317103	usd
CY2023Q4	kndi	Accumulated Impairment For Intangible Assets AccumulatedImpairmentForIntangibleAssets	-3510236	usd
CY2022Q4	kndi	Accumulated Impairment For Intangible Assets AccumulatedImpairmentForIntangibleAssets	-2631465	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6395825	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7994112	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1489657	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1965490	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1718689	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1657930	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1426023	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	820390	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	772793	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6395825	usd
CY2023Q4	kndi	Cost Of Land Use Rights CostOfLandUseRights	3716267	usd
CY2022Q4	kndi	Cost Of Land Use Rights CostOfLandUseRights	3809211	usd
CY2023Q4	kndi	Accumulated Amortizationof Land Right Use Assets AccumulatedAmortizationofLandRightUseAssets	961825	usd
CY2022Q4	kndi	Accumulated Amortizationof Land Right Use Assets AccumulatedAmortizationofLandRightUseAssets	899261	usd
CY2023Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	2754442	usd
CY2022Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	2909950	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	84471	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	84471	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	84471	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	84471	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	84471	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	84471	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	2332087	usd
CY2023Q4	kndi	Land Use Rights Net LandUseRightsNet	2754442	usd
CY2023Q4	kndi	Prepayments For New Product Molds PrepaymentsForNewProductMolds	3738418	usd
CY2022Q4	kndi	Prepayments For New Product Molds PrepaymentsForNewProductMolds	3917226	usd
CY2023Q4	kndi	Other Long Term Asset Right Of Use Asset OtherLongTermAssetRightOfUseAsset	5889690	usd
CY2022Q4	kndi	Other Long Term Asset Right Of Use Asset OtherLongTermAssetRightOfUseAsset	6383824	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	365022	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	329861	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9993130	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10630911	usd
CY2023Q4	kndi	Net Value Of Land Use Right NetValueOfLandUseRight	5443448	usd
CY2022Q4	kndi	Net Value Of Land Use Right NetValueOfLandUseRight	5697720	usd
CY2023	us-gaap	Lease Cost LeaseCost	446242	usd
CY2022	us-gaap	Lease Cost LeaseCost	686104	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.15	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.5192	pure
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3500000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0365	pure
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	13300000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1599668	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-26465	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	203236	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-461045	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1802904	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-487510	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1885374	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3334633	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	650434	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-81257	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2471114	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	790053	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	898290	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	1984855	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	3830387	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	2315146	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1516020	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1672428	usd
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-431	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-538545	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	467366	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2800862	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	70708	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	84045	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-74094	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1302192	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1802904	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-487510	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	6388121	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	6759952	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9412846	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8547725	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	15800967	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	15307677	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	345033	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	212143	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-218406	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-207905	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	763627	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1146339	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1222344	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	426504	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2549410	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1992891	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13251557	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13314786	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	13400638	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	13260631	usd
CY2023Q4	kndi	Net Deferred Tax Assetsliabilities Net Of Valuation Allowance NetDeferredTaxAssetsliabilitiesNetOfValuationAllowance	149081	usd
CY2022Q4	kndi	Net Deferred Tax Assetsliabilities Net Of Valuation Allowance NetDeferredTaxAssetsliabilitiesNetOfValuationAllowance	-54155	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13400000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3472671	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13338534	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13260631	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	467366	usd
CY2023	kndi	Prior Year True Up PriorYearTrueUp	-5478	usd
CY2023	kndi	Exchange Rate Difference ExchangeRateDifference	-321881	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13400638	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.25	pure
CY2023	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	2421539	usd
CY2022	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	1202615	usd
CY2023	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.03
CY2022	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.02
CY2022Q4	kndi	Contingent Consideration Liability ContingentConsiderationLiability	1803000	usd
CY2020Q4	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	3500000	usd
CY2021Q4	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	2800000	usd
CY2022Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P48M
CY2022Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.037	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	490198	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	490198	usd
CY2023Q4	kndi	Operating Lease Rights Of Use Asset OperatingLeaseRightsOfUseAsset	5889690	usd
CY2023Q4	us-gaap	Lease Deposit Liability LeaseDepositLiability	445948	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	338233	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	355541	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	338233	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	355541	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	218924	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	227024	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	50000000	cny
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7900000	usd
CY2023	kndi	Supplementary Agreement Description SupplementaryAgreementDescription	Pursuant to the No.2 Supplementary Agreement, the Transferors have the right to obtain 858,770 KNDI shares in each of the below-mentioned periods, provided that Jiangxi Huiyi achieves a net income of 1) RMB 8 million yuan or more during the period from July 1, 2021 to September 30, 2022 (“Period I”); 2) RMB 15 million yuan or more during the period from October 1, 2022 to September 30, 2023 (“Period II”); 3) RMB 15 million yuan or more during the period from October 1, 2023 to September 30, 2024 (“Period III”). If the net income of Jiangxi Huiyi fails to reach the respective target number in any of the three periods, the shares that the Transferors are entitled to obtain in that period will be adjusted accordingly: 1) if the difference between the net income in each Period and its Target Number is less than or equivalent to 20% of its Target Number (RMB 8 Million in Period I or RMB 15 Million in Period II or Period III), the transferee or KNDI has right to directly subtract 171,754 KNDI shares from the total make good shares, and the Transferor are entitled to obtain 687,016 KNDI shares; 2) if the difference between the net income in each Period and its Target Number (RMB 8 Million in Period I or RMB 15 Million in Period II or Period III) is more than 20% of its Target Number but less than 40% of its Target Number, the transferee or KNDI has the right to directly subtract 343,508 KNDI shares from the total make good shares, and the Transferors have the right to obtain 515,262 KNDI shares; 3) if the difference between the net income in each Period and its Target Number (RMB 8 Million in Period I or RMB 15 Million in Period II or Period III) is greater than or equal to 40% of its Target Number, the transferee of KNDI has the right to directly subtract 858,770 KNDI shares from the total make good shares, and the Transferors will not have the right to obtain any shares in such year.
CY2022Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	858770	shares
CY2023Q4	kndi	Contingent Consideration Liability ContingentConsiderationLiability	2693000	usd
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	2693000	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	1803000	usd
CY2023Q4	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	30000000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	184566	shares
CY2023	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	2.75
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	9807820	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	300000	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1083000	usd
CY2022Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	6704829	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7983	pure
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0327	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.96
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2023Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	172601	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7808	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0381	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	900000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.72
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5000000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.07
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5900000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.24
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	68019	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.96
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1666661	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.07
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4301358	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.7
CY2015Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	900000	shares
CY2015Q2	us-gaap	Option Contract Indexed To Equity Settlement Share Fair Value Per Share OptionContractIndexedToEquitySettlementShareFairValuePerShare	8.16
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5000000	shares
CY2022Q3	us-gaap	Option Contract Indexed To Equity Settlement Share Fair Value Per Share OptionContractIndexedToEquitySettlementShareFairValuePerShare	1.34
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	68019	shares
CY2023Q3	us-gaap	Option Contract Indexed To Equity Settlement Share Fair Value Per Share OptionContractIndexedToEquitySettlementShareFairValuePerShare	2.54
CY2023	kndi	Net Profit NetProfit	150000000	cny
CY2023	kndi	Net Profit NetProfit	21719613	usd
CY2023	kndi	Annual Net Profit AnnualNetProfit	50000000	cny
CY2023	kndi	Annual Net Profit AnnualNetProfit	7239871	usd
CY2023	kndi	Incentive Shares IncentiveShares	5957811	shares
CY2023	kndi	Net Profit Percentage NetProfitPercentage	0.60	pure
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	5957811	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1985937	shares
CY2023	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	6500743	usd
CY2022	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	694810	usd
CY2023Q1	us-gaap	Financial Guarantee Insurance Contracts Premiums Receivable Adjustment FinancialGuaranteeInsuranceContractsPremiumsReceivableAdjustment	2828934	usd
CY2023Q1	us-gaap	Financial Guarantee Insurance Contracts Premiums Receivable Adjustment FinancialGuaranteeInsuranceContractsPremiumsReceivableAdjustment	20000000	cny
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	710000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Revenues Revenues	123599232	usd
CY2022	us-gaap	Revenues Revenues	117813049	usd
CY2023	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	239476	usd
CY2023	us-gaap	Revenues Revenues	123599232	usd
CY2022	us-gaap	Revenues Revenues	117813049	usd
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	239476	usd
CY2023	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	13000000	usd
CY2023	kndi	Trading Days TradingDays	P20D
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.29
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023	kndi	Equity Transfer Agreement Description EquityTransferAgreementDescription	Pursuant to the terms of the Equity Transfer Agreement and the Supplementary Agreement, dated as of March 12, 2024, the escrow restrictions on the KNDI Stock shall be removed sequentially based on the following conditions: 1) when NGI achieves pretax income of $4.6 million or more (“Profit Target I”) during the period from December 1, 2023 to November 30, 2024, 2,431,612 shares of KNDI Stock Transferor holds shall be fully vested by removing the escrow restriction. Notwithstanding the above, the Transferor, on December 31, 2023, can apply for vesting certain number of shares, but no more than 1,418,440 shares, with its value equal to the actual amount of pre-tax income achieved hereinunder (for example: if the pre-tax income is $3.5 million, 1,063,830 shares (3,500,000/3.29=1,063,830) shall be fully vested and without escrow restriction); 2) when NGI achieves pretax income of $5.25 million or more (“Profit Target II”) during the period from December 1, 2024 to November 30, 2025, 759,878 shares of KNDI Stock Transferor holds shall be fully vested by removing its escrow restriction; and 3) when NGI achieves pretax income of $6 million or more (“Profit Target III”, collectively with Profit Target I, and Profit Target II, “Profit Targets”) during the period from December 1, 2025 to November 30, 2026, 759,878 shares of KNDI Stock Transferor holds shall be fully vested by removing the escrow restriction. If NGI fails to reach any of the Profit Targets in any period as mentioned above, the number of KNDI Stock to be removed escrow restriction in that period shall be adjusted based on the percentage of the actual achieved pretax income. If there is any loss incurred in that period, the Transferor shall assume the loss.
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	2700000	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	2693000	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	2693000	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	45267	usd
CY2023Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	1030000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0.0000002	usd
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	0.006641	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	kndi	Constructions In Progress Gross ConstructionsInProgressGross		usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments		usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2023	kndi	Stock Issued During Period Value Cancellation Of The Treasury Stock StockIssuedDuringPeriodValueCancellationOfTheTreasuryStock		usd
CY2022	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments		usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	kndi	Common Stock Issued From Settlement Of Payables Related To Acquisitions CommonStockIssuedFromSettlementOfPayablesRelatedToAcquisitions		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent		usd
CY2022	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001316517

Files In Submission

Name	View Source	Status
0001213900-24-022676-index-headers.html	Edgar Link	pending
0001213900-24-022676-index.html	Edgar Link	pending
0001213900-24-022676.txt	Edgar Link	pending
0001213900-24-022676-xbrl.zip	Edgar Link	pending
ea0201374-10k_kanditech.htm	Edgar Link	pending
ea020137401ex10-24_kanditech.htm	Edgar Link	pending
ea020137401ex10-25_kanditech.htm	Edgar Link	pending
ea020137401ex10-26_kanditech.htm	Edgar Link	pending
ea020137401ex10-2_kanditech.htm	Edgar Link	pending
ea020137401ex21-1_kanditech.htm	Edgar Link	pending
ea020137401ex23-1_kanditech.htm	Edgar Link	pending
ea020137401ex31-1_kanditech.htm	Edgar Link	pending
ea020137401ex31-2_kanditech.htm	Edgar Link	pending
ea020137401ex32-1_kanditech.htm	Edgar Link	pending
ea020137401ex97-1_kanditech.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex23-1_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
kndi-20231231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kndi-20231231_cal.xml	Edgar Link	unprocessable
kndi-20231231_def.xml	Edgar Link	unprocessable
ea0201374-10k_kanditech_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kndi-20231231_lab.xml	Edgar Link	unprocessable
kndi-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Kandi Technologies Group, Inc.

2024 Q1 Form 10-K Financial Statement

#000121390024022676 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission